Search all medical codes

Contact with and (suspected) exposure to infections with a predominantly sexual mode of transmission

ICD10CM code

Medical Policies and Guidelines for Contact with and (suspected) exposure to infections with a predominantly sexual mode of transmission

Related policies from health plans

Nucleic Acid Pathogen Testing - (0530)
Nucleic Acid Pathogen Testing - (0530)
Nucleic Acid Pathogen Testing - (0530)
Nucleic Acid Pathogen Testing - (0530)
Nucleic Acid Pathogen Testing - (0530)
Nucleic Acid Pathogen Testing - (0530)
Nucleic Acid Pathogen Testing - (0530)
Nucleic Acid Pathogen Testing - (0530)
Preventive Care Services - (A004)

Similar Codes


ICD10CM codes

Z20.2 - Contact with and (suspected) exposure to infections with a predominantly sexual mode of transmission
Z11.3 - Encounter for screening for infections with a predominantly sexual mode of transmission
Z22.4 - Carrier of infections with a predominantly sexual mode of transmission
Z20.8 - Contact with and (suspected) exposure to other communicable diseases
Z20.9 - Contact with and (suspected) exposure to unspecified communicable disease
Z20.89 - Contact with and (suspected) exposure to other communicable diseases
Z20.6 - Contact with and (suspected) exposure to human immunodeficiency virus [HIV]
Z20.828 - Contact with and (suspected) exposure to other viral communicable diseases
Z20.82 - Contact with and (suspected) exposure to other viral communicable diseases
Z20 - Contact with and (suspected) exposure to communicable diseases

HCPCS codes

S8301 - Infection control supplies, not otherwise specified
G9228 - Chlamydia, gonorrhea and syphilis screening results documented (report when results are present for
G0445 - High intensity behavioral counseling to prevent sexually transmitted infection; face-to-face, indivi
H2029 - Sexual offender treatment service, per diem
G9416 - Patient had one tetanus, diphtheria toxoids and acellular pertussis vaccine (tdap) on or between the
G0432 - Infectious agent antibody detection by enzyme immunoassay (eia) technique, hiv-1 and/or hiv-2, scree
U0004 - 2019-nCoV Coronavirus, SARS-CoV-2/2019-nCoV (COVID-19), any technique, multiple types or subtypes (i
J3485 - Injection, zidovudine, 10 mg
G8959 - Clinician treating major depressive disorder communicates to clinician treating comorbid condition
G9223 - Pneumocystis jiroveci pneumonia prophylaxis prescribed within 3 months of low cd4+ cell count below

CPT4 codes

4293F - Patient screened for high-risk sexual behavior (HIV)
87110 - Culture, chlamydia, any source
3511F - Chlamydia and gonorrhea screenings documented as performed (HIV)
00920 - Anesthesia for procedures on male genitalia (including open urethral procedures); not otherwise spec
99170 - Anogenital examination, magnified, in childhood for suspected trauma, including image recording when
87510 - Infectious agent detection by nucleic acid (DNA or RNA); Gardnerella vaginalis, direct probe techniq
12041 - Repair, intermediate, wounds of neck, hands, feet and/or external genitalia; 2.5 cm or less
87810 - Infectious agent antigen detection by immunoassay with direct optical observation; Chlamydia trachom
12047 - Repair, intermediate, wounds of neck, hands, feet and/or external genitalia; over 30.0 cm
87808 - Infectious agent antigen detection by immunoassay with direct optical observation; Trichomonas vagin